|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Paolo Palatini , Enrico Agabiti-Rosei , Giuseppe ManciaPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: 1st ed. 2022 Weight: 0.361kg ISBN: 9783031079603ISBN 10: 3031079604 Pages: 223 Publication Date: 08 September 2023 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of Contents1 Hemodynamics of exercise testing and sports activities.- 2 Veronique Cornelissen: effect of physical activity on BP and prevention of hypertension.- 3 Effect of regular exercise on autonomic nervous system activity.- 4 Effect of physical activity on endothelial function.- 5 Exercise and microcirdulation in hypertension.- 6 Effect of regular physical activity on Arterial Distensibility.- 7 Physiological versus pathological LVH in the hypertensive athlete.- 8 Atrial fibrillation and Sport; A challenging problem?.- 9 The Metabolic Syndrome: effect of physical activity on arterial elasticity.- 10 Effect of exercise training on clinical outcomes in patients with diabetes.- 11 Effects of exercise in hypertension of youth.- 12 The beneficial role of exercise training in the elderly with hypertension.- 13 Exercise for systemic and pulmonary hypertension: killing two birds with one stone.- 14 High altitude and blood pressure: clinical implications.- 15 Treatment of the hypertensive athlete.ReviewsAuthor InformationProfessor Palatini received his medical education at the University of Padua, Italy. He worked for 5 years in the Laboratory of Professor Stevo Julius at the University of Michigan (USA), where he received the local Honour. In 2009, he was appointed as Lecturer of the year by the Belgian Hypertension Society; in the same year, he was appointed as a lecturer by the Indian Society of Cardiology and delivered lectures in six Indian towns. He received the Alberto Zanchetti Award of the ESH in 2021.Coordinator of several international and national studies of hypertension and of clinical pharmacology, he serves on the Editorial Board of several International Journals, including Hypertension and the Journal of Hypertension. Prof. Palatini published over 500 original articles and reviews in international journals for a global IF>2600. Enrico Agabiti-Rosei is Professor Emeritus at Universityof Brescia, Italy, where he was the Director of the Medical Clinic, and Chairman of both the Hospital Clinical Department of Medicine, and the University Department of Clinical and Experimental Sciences, until the end of 2017. He has been also the Director of the post-graduate School of Internal Medicine. He specialized in Cardiology and Internal Medicine at the University of Pisa and spent few years abroad in prestigious international research centers as Research Fellow or visiting Professor: in Glasgow, GB, at the BP Unit, in Basel, Switzerland, at Kantonsspital, in Cleveland, Ohio, at the Cleveland Clinic. He has received the Peter Sleight Award of the ESH in 2011. Among others, he was Member of the Task Force appointed to write the 2018 ESC/ESH Guidelines for Hypertension. Prof. Agabiti Rosei was Chairman of the WG on Hypertension and the Heart of the ESC and of the ESH, and was also President of the Italian Society of Hypertension (2005-2007) and of the European Society of Hypertension (2015-2017). Giuseppe Mancia is Emeritus Professor of the University of Milano-Bicocca. He served as Full Professor of Medicine and Director of the Department of Medicine at the San Gerardo Hospital, Monza, Italy. He is President of the European Society of Hypertension (ESH) Foundation and Chairman of the ESH Educational Committee. He has been President of ESH, the International Society of Hypertension, the Italian Society of Hypertension and the European Society of Clinical Investigation. He has received numerous international Awards and Degrees Honoris Causa for his research on hypertension and cardiovascular diseases and has chaired the Task Force of the European Hypertension Guidelines since 2003. He is an highly cited investigator. Tab Content 6Author Website:Countries AvailableAll regions |